Biomarkers estimating baseline mortality risk for neonatal sepsis: nPERSEVERE: neonate-specific sepsis biomarker risk model

Faris N. Al Gharaibeh,Patrick Lahni,Matthew N. Alder,Hector R. Wong
DOI: https://doi.org/10.1038/s41390-022-02414-z
IF: 3.953
2022-12-14
Pediatric Research
Abstract:Prognostic biomarker research neonatal sepsis is lacking. We assessed the utility of a validated pediatric prognostic tool called PERSEVERE II that uses decision tree methodology to predict mortality at discharge in neonates who experienced sepsis.
pediatrics
What problem does this paper attempt to address?